אודות פרק זה
BUFFALO, NY – September 17, 2026 – A new #commentary was #published in Volume 17 of Oncotarget on September 11, 2026, titled “Are both COVID-19 and COVID-19 vaccines associated with cancer?”
The paper was authored by Raphael Lataster, an independent researcher at the University of Sydney, and responds to a recent Oncotarget review by Charlotte Kuperwasser and Wafik S. El-Deiry examining published reports concerning cancer following COVID-19 vaccination or infection.
Lataster highlights research concerning potential associations between COVID-19 and cancer and discusses mechanisms proposed in the literature. He argues that similar mechanisms reported in connection with COVID-19 vaccination warrant consideration and further study.
The commentary also highlights differences in how evidence concerning COVID-19 vaccines and cancer has been evaluated in the scientific literature. He calls for the same evidentiary standards to be applied when considering potential links between COVID-19 infection, vaccination, and cancer.
“Such inquiries should proceed without preconceptions, applying the same evidentiary standards regardless of whether findings implicate infection, vaccination, or both.”
The commentary does not establish a causal relationship between COVID-19 vaccination and cancer. Rather, it calls for potential associations and biological mechanisms to be investigated without predetermined conclusions and with appropriate consideration of alternative explanations and the limitations of observational evidence.
DOI - https://doi.org/10.18632/oncotarget.28918
Correspondence to - Raphael Lataster - okaythennews@gmail.com (ORCID: https://orcid.org/0000-0002-6670-1702)
Preview video - https://www.youtube.com/watch?v=uSbIKNe3Hho
Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28918
Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/
Keywords - cancer, COVID-19, COVID-19 vaccines, double standards
To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us:
Facebook - https://www.facebook.com/Oncotarget/
X - https://twitter.com/oncotarget
Instagram - https://www.instagram.com/oncotargetjrnl/
YouTube - https://www.youtube.com/@OncotargetJournal
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/
Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh
MEDIA@IMPACTJOURNALS.COM
The paper was authored by Raphael Lataster, an independent researcher at the University of Sydney, and responds to a recent Oncotarget review by Charlotte Kuperwasser and Wafik S. El-Deiry examining published reports concerning cancer following COVID-19 vaccination or infection.
Lataster highlights research concerning potential associations between COVID-19 and cancer and discusses mechanisms proposed in the literature. He argues that similar mechanisms reported in connection with COVID-19 vaccination warrant consideration and further study.
The commentary also highlights differences in how evidence concerning COVID-19 vaccines and cancer has been evaluated in the scientific literature. He calls for the same evidentiary standards to be applied when considering potential links between COVID-19 infection, vaccination, and cancer.
“Such inquiries should proceed without preconceptions, applying the same evidentiary standards regardless of whether findings implicate infection, vaccination, or both.”
The commentary does not establish a causal relationship between COVID-19 vaccination and cancer. Rather, it calls for potential associations and biological mechanisms to be investigated without predetermined conclusions and with appropriate consideration of alternative explanations and the limitations of observational evidence.
DOI - https://doi.org/10.18632/oncotarget.28918
Correspondence to - Raphael Lataster - okaythennews@gmail.com (ORCID: https://orcid.org/0000-0002-6670-1702)
Preview video - https://www.youtube.com/watch?v=uSbIKNe3Hho
Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28918
Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/
Keywords - cancer, COVID-19, COVID-19 vaccines, double standards
To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us:
Facebook - https://www.facebook.com/Oncotarget/
X - https://twitter.com/oncotarget
Instagram - https://www.instagram.com/oncotargetjrnl/
YouTube - https://www.youtube.com/@OncotargetJournal
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/
Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh
MEDIA@IMPACTJOURNALS.COM
אנגלית
ארצות הברית
תעתיק 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
פרקים אחרים בפודקאסט הזה
BUFFALO, NY – August 31, 2026 – A new #editorial was published in Volume 17 of Oncotarget on June 8, 2026, titled “Tumor infiltrating lymphocyte (TIL) therapy for treating the solid tumors: Challenges and future perspectives.”
The editorial was led by first and corresponding author Bhartendra Sha…
BUFFALO, NY – September 1, 2026 – A new #review was published in Volume 17 of Oncotarget on August 28, 2026, titled “Emerging biomedical imaging applications of tumor-derived extracellular vesicles for premetastatic niche detection: Biological rationale, engineering strategies, and translational c…
Head and neck squamous cell carcinoma (HNSCC) can return even after patients complete surgery, radiation, chemotherapy, or combinations of these treatments. Preventing recurrence therefore remains an important challenge in head and neck cancer care. Human papillomavirus (HPV), particularly HPV typ…
BUFFALO, NY – September 9, 2026 – A new #review was #published in Volume 17 of Oncotarget on September 8, 2026, titled “Re-expression of MHC-I to treat CNS cancers.”
The review examines emerging strategies to restore major histocompatibility complex class I (MHC-I) expression in cancers of the c…
BUFFALO, NY - September 8, 2026 – Oncotarget is proud to support the WIN 2026 Symposium, organized by the Worldwide Innovative Networking (WIN) Consortium, taking place October 2–3, 2026, at the Rhode Island Convention Center in Providence.
The two-day symposium, themed “Precision Oncology: Innov…
הצהרה: הפודקאסט והגרפיקה המוטבעים בדף זה הם מ-Oncotarget Podcast, שהוא רכושו של בעליו ואינו קשור או מאושר על ידי Listen Notes, Inc.